Specialized Brain-on-Chip capabilities for CROs supporting neuroscience research and preclinical development.
Contract research organizations play a key role in supporting pharmaceutical and biotech companies across research, preclinical development and experimental validation.
As neuroscience programs become increasingly complex, CROs may need access to specialized technologies that go beyond conventional testing systems. Advanced in vitro models, functional neuronal readouts and human-relevant platforms can help strengthen the quality and translational value of preclinical studies.
AxCellerate works with CROs as a scientific and technological partner, providing Brain-on-Chip capabilities that can complement existing service portfolios and support client projects in neuroscience drug discovery, safety assessment, disease modelling and target validation.
AxCellerate’s Brain-on-Chip platform allows CROs to access advanced preclinical neuroscience capabilities without the need to develop the technology internally.
For CROs, this can support:
AxCellerate enables CROs to integrate specialized Brain-on-Chip and human-relevant neuronal modelling capabilities into their neuroscience-related services.
Three-dimensional human-derived neuronal models can help provide more meaningful insights into neuronal activity, compound response and disease-related mechanisms.
Electrophysiological recording capabilities support the generation of functional data that can add value to preclinical study packages.
AxCellerate can help CROs respond to specific research questions involving neurotoxicity, disease modelling, target validation or translational neuroscience.
Projects can be structured according to the CRO’s client needs, study objectives and required level of scientific support.
Partnering with AxCellerate can help CROs strengthen their positioning in advanced neuroscience preclinical research.
AxCellerate does not replace the role of the CRO. It complements it with a specialized technological platform and scientific expertise focused on human-relevant preclinical neuroscience.
Our services can be integrated into broader preclinical programs, used to answer specific biological questions or proposed as an advanced testing option for clients developing CNS-related therapies.
By combining AxCellerate’s Brain-on-Chip technology with the CRO’s project management, regulatory experience and client relationships, collaborations can create stronger and more complete preclinical research solutions.
